Research programme: Therapore-based vaccines - AVANTAlternative Names: Therapore®-based vaccines research programme - AVANT
Latest Information Update: 02 Aug 2006
At a glance
- Originator AVANT Immunotherapeutics
- Class Cancer vaccines; Viral hepatitis vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer; Hepatitis B; Hepatitis C
Most Recent Events
- 02 Aug 2006 This programme is still in active development
- 23 Jul 2004 Preclinical trials in Hepatitis C treatment in USA (unspecified route)
- 23 Jul 2004 Preclinical trials in Hepatitis C prevention in USA (unspecified route)